60 related articles for article (PubMed ID: 11221498)
1. Galactorrhea induced by paroxetine.
Morrison J; Remick RA; Leung M; Wrixon KJ; Bebb RA
Can J Psychiatry; 2001 Feb; 46(1):88-9. PubMed ID: 11221498
[No Abstract] [Full Text] [Related]
2. A case of galactorrhea during paroxetine treatment.
Evrensel A; Önen Ünsalver B; Akyol A; Ceylan ME
Int J Psychiatry Med; 2016 Apr; 51(3):302-5. PubMed ID: 27284122
[TBL] [Abstract][Full Text] [Related]
3. Ziprasidone-induced galactorrhea: a case report.
Kopecek M; Bares M; Mohr P
Neuro Endocrinol Lett; 2005 Feb; 26(1):69-70. PubMed ID: 15726024
[TBL] [Abstract][Full Text] [Related]
4. Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients.
Hwang JP; Yang CH; Tsai SJ
Int J Geriatr Psychiatry; 2004 Feb; 19(2):189-90. PubMed ID: 14758586
[No Abstract] [Full Text] [Related]
5. A case of paroxetine-induced galactorrhea.
Davenport E; Velamoor R
Can J Psychiatry; 2002 Nov; 47(9):890-1. PubMed ID: 12500767
[No Abstract] [Full Text] [Related]
6. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
7. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
[TBL] [Abstract][Full Text] [Related]
8. Risperidone-associated galactorrhea in a male teenager.
Gupta S; Frank B; Madhusoodanan S
J Am Acad Child Adolesc Psychiatry; 2001 May; 40(5):504-5. PubMed ID: 11349691
[No Abstract] [Full Text] [Related]
9. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
Greist J; McNamara RK; Mallinckrodt CH; Rayamajhi JN; Raskin J
Clin Ther; 2004 Sep; 26(9):1446-55. PubMed ID: 15531007
[TBL] [Abstract][Full Text] [Related]
10. Galactorrhea during treatment with trimipramine. A case report.
Wolfsperger M; Greil W
Pharmacopsychiatry; 2005 Nov; 38(6):326-7. PubMed ID: 16342006
[TBL] [Abstract][Full Text] [Related]
11. [Galactorrhea induced by paroxetine].
Gayo Otero M; Ruiz Ripoll A; García Pares G; Basagaña G
Med Clin (Barc); 2002 May; 118(19):758-9. PubMed ID: 12049712
[No Abstract] [Full Text] [Related]
12. Efficacy and tolerability of controlled-release paroxetine.
Golden RN
Psychopharmacol Bull; 2003; 37 Suppl 1():176-86. PubMed ID: 14566210
[TBL] [Abstract][Full Text] [Related]
13. Paroxetine in the treatment of depressed patients with haematological malignancy: an open-label study.
Pae CU; Kim YJ; Won WY; Kim HJ; Lee S; Lee CU; Lee SJ; Kim DW; Lee C; Min WS; Kim CC; Paik IH; Serretti A
Hum Psychopharmacol; 2004 Jan; 19(1):25-9. PubMed ID: 14716708
[TBL] [Abstract][Full Text] [Related]
14. Reversible paroxetine-induced symptomatic hypothyroidism.
Takahashi M; Sawayama E; Sawayama T; Miyaoka H
Pharmacopsychiatry; 2007 Sep; 40(5):201-2. PubMed ID: 17874352
[No Abstract] [Full Text] [Related]
15. Paroxetine induced galactorrhoea - A case report.
Kumar PNS; Gopalakrishnan A
Asian J Psychiatr; 2018 Apr; 34():31-32. PubMed ID: 29631147
[No Abstract] [Full Text] [Related]
16. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
Daléry J; Aubin V
Encephale; 2001; 27(1):71-81. PubMed ID: 11294041
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis.
Ehde DM; Kraft GH; Chwastiak L; Sullivan MD; Gibbons LE; Bombardier CH; Wadhwani R
Gen Hosp Psychiatry; 2008; 30(1):40-8. PubMed ID: 18164939
[TBL] [Abstract][Full Text] [Related]
18. Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder".
Hashimoto K
J Clin Psychopharmacol; 2009 Aug; 29(4):411-2; author reply 412. PubMed ID: 19593196
[No Abstract] [Full Text] [Related]
19. Depression and psoriasis comorbidity. Treatment with paroxetine: two case reports.
Luis Blay S
Ann Clin Psychiatry; 2006; 18(4):271-2. PubMed ID: 17162628
[No Abstract] [Full Text] [Related]
20. MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression.
Mihaljevic Peles A; Bozina N; Sagud M; Rojnic Kuzman M; Lovric M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1439-44. PubMed ID: 18550244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
